Apply to Cambridge Angels

Apply to Cambridge Angels

PhoreMost and ThinkCyte partner to develop AI-based drug discovery

14 Dec

Written By Alexandra Collingbourne

Alexandra Collingbourne

Qkine raises £4.3m scale-up capital and prepares HQ move

MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform